Z-2880-2026 Class III Ongoing
FDA device recall Z-2880-2026 was initiated by Siemens Healthcare Diagnostics, Inc. on Jun 26, 2026 and is designated Class III. Reason for recall: Out-of-specification sodium azide concentration in Syva Emit Disopyramide Enzyme Immunoassay Calibrator Lot U1. While the assay results were not impacted, the overall health risk to lab technicians… The recall status is ongoing. Affected quantity: 8 US; 44 OUS.
Recall details
- Product Type
- Devices
- Report Date
- Aug 12, 2026
- Initiation Date
- Jun 26, 2026
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 8 US; 44 OUS
Product description
Syva Emit Disopyramide Assay Enzyme Immunoassay, Lidocaine SMN 10445370 Catalog No 6N319UL
Reason for recall
Out-of-specification sodium azide concentration in Syva Emit Disopyramide Enzyme Immunoassay Calibrator Lot U1. While the assay results were not impacted, the overall health risk to lab technicians due to this issue is low, as exposure is limited by small volumes and a 0.2% post-reconstitution sodium azide concentration, with the worst outcome being mild skin or eye irritation and no serious harm anticipated.
Distribution pattern
Worldwide - US Nationwide distribution in the states of CA and VA. The country of Japan.
Code information
UDI-DI 00842768001406 Lot U1
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-2880-2026
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026